Clover Health Investments, Corp. CLOV is scheduled to report third-quarter 2024 results on Nov. 6, after the closing bell.In the last reported quarter, the company delivered earnings per share of a penny...
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, October 4:Omnicell, Inc. OMCL: This pharmaceutical technology company has a Zacks Rank #1 and witnessed...
/PRNewswire/ -- EmpiRx Health, the industry's only value-based PBM, today announced that the company's president, Danny Sanchez, has been named Chief Executive...
Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference...